Singapore markets closed

Wellbeing Digital Sciences Inc. (KONEF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 04:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0001
Open0.0001
BidN/A x N/A
AskN/A x N/A
Day's range0.0001 - 0.0001
52-week range0.0001 - 0.0399
Volume1,000
Avg. volume15
Market cap44.342M
Beta (5Y monthly)3.50
PE ratio (TTM)N/A
EPS (TTM)-0.3600
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit and Psychedelic Science Conference

    VANCOUVER, British Columbia, June 19, 2023--Wellbeing Digital Sciences Inc. ("Wellbeing" or the "Company") (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that its wholly owned subsidiary KGK Sciences Inc. ("KGK" or the "Subsidiary"), will participate at the upcoming Mushroom Summit, t

  • Business Wire

    Wellbeing Digital Enters into Share Purchase Agreement with Cardinal Group

    VANCOUVER, British Columbia, June 16, 2023--Wellbeing Digital Sciences Inc. ("Wellbeing" or the "Company") (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that the Company has entered into a share purchase agreement (the "Purchase Agreement"), dated June 7, 2023, with Cardinal Group In

  • Business Wire

    Wellbeing Digital Subsidiary KGK Science to Participate at the Nutrition Industry Association Spring Conference

    VANCOUVER, British Columbia, May 25, 2023--Wellbeing Digital Sciences Inc. ("Wellbeing" or the "Company") (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that its subsidiary KGK Science Inc. ("KGK" or the "Subsidiary") will participate at the upcoming Nutrition Industry Association ("N